Teaching Intro to Business, Personal Finance, and Marketing: Sports & Entertainment classes. Faculty advisor to the Model UN and Investment clubs. Volunteer assistant coach for boys' varsity basketball team.

Volunteer mentor at organization that provides mentoring and financial support to promising graduates of Boston Public Schools by giving them a chance at a college education, assisting them in overcoming hurdles to earn their degree and become stronger contributors to the Greater Boston community.

Member of Board of Directors at clinical stage company developing a proprietary proliposomal intracavitary paclitaxel drug delivery platform designed to enhance the therapeutic index of proven cancer drugs, which results in more effective treatments for intracavitary cancers. LIPAC’s lead drug candidate, LiPax™, is a locally delivered formulation of paclitaxel in clinical development for non-muscle invasive bladder cancer (NMIBC) that has demonstrated impressive initial clinical activity while being very well tolerated.

Head of business development at company that aims to bring impactful new medicines to patients by combining the strengths of an asset-centric model with the benefits of scale and diversification typical of larger R&D organizations. Centessa’s programs range from discovery-stage to late-stage development and include diverse therapeutic areas such as oncology, hematology, immunology/inflammation, neuroscience, hepatology, pulmonology and nephrology.

Board member at clinical stage company developing innovative treatments for specialty indications based on repositioning neurologically active compounds.

Member of executive leadership team at public company focused on innovative cellular therapies in oncology. Responsible for Business Development, Corporate Strategy, Investor Relations and Corporate Communications functions. Helped take the company public and part of > $125M in public equity financing.

Member of leadership team at life science transaction advisory firm that assists companies in sell-side, buy-side and financing transactions. Sold client engagements, led transaction processes, managed client relationships, mentored / guided internal team of Associates and Analysts and coordinated Locust Walk Institute business development training course.

Member of company’s executive leadership team; led out-licensing, in-licensing and alliance management activities;Re-structured strategic alliances with Purdue/Mundipharma and Millennium/Takeda

Led partnering efforts that attracted multiple terms sheets at venture backed regenerative medicine company, which was ultimately acquired by Shire in 2012

In-licensed clinical stage oncology compounds from Novartis and Bayer-Schering;Member of company’s IPO transaction team

Led partnering efforts for MG Biotherapeutics joint venture between Genzyme and Medtronic in the field of cardiac cell therapy

Starting Center on professional basketball team in Israel